EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC-ND 4.0

Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study

Alexander Krahforst, Hamideh Yadegari, Anna Pavlova, Behnaz Pezeshkpoor, Jens Müller, Bernd Pötzsch, Ute Scholz, Heinrich Richter, Heiner Trobisch, Karin Liebscher, Martin Olivieri, Karolin Trautmann-Grill und 3 weitere

Journal of Thrombosis and Haemostasis · 2024-11 · 22 (11) · 3010-3034

DOI: 10.1016/j.jtha.2024.06.026 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of Thrombosis and Haemostasis, 2024-11. Verfasst von Alexander Krahforst und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany. Hauptthemen laut MEDLINE: von Willebrand Factor, Mutation, Phenotype, Genetic Association Studies. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Von Willebrand disease (VWD), the most prevalent hereditary bleeding disorder, results from deficiency of von Willebrand factor (VWF). OBJECTIVES: This large cohort study aims to offer a comprehensive exploration of mutation spectra and laboratory features in quantitative VWF deficiencies, shedding light on genetic underpinnings and genotype-phenotype associations. METHODS: Our cohort consisted of 221 Caucasian index patients with quantitative VWD, along with 47 individuals whose plasma VWF levels fell within the lower normal boundaries (50-70 IU/dL). We conducted comprehensive VWF assays and genetic analyses, encompassing VWF gene sequencing, copy number variation investigations, and bioinformatic assessments. RESULTS: Following International Society on Thrombosis and Haemostasis-Scientific and Standardization Committee VWF guidelines, 77 index patients were characterized as having type 1 VWD (VWF antigen [VWF:Ag] < 30 IU/dL), 111 as having type 1 VWD (VWF:Ag, 30-50 IU/dL), and 33 as having type 3 VWD. Mutation detection rates were 88%, 65%, and 92%, respectively. Notably, blood group O overrepresentation was evident in type 1 with VWF:Ag of 30 to 50 IU/dL, particularly among mutation-negative patients, suggesting a potential causal role of blood group O. A total of 223 VWF variants, comprising 147 distinct variations, were identified in quantitative VWD patients, of which 57 were novel variants (39%). Additionally, approximately 70% of individuals with VWF levels within the lower normal boundaries (50-70 IU/dL) displayed VWF variants. CONCLUSION: Our data advance our understanding of the molecular mechanisms underlying quantitative VWD, offering valuable insights for future research and clinical management. Distinct mutation patterns were observed among subgroups, particularly the contrast between type 1 VWD (VWF:Ag < 30 IU/dL) and type 1 VWD (VWF:Ag, 30-50 IU/dL), an area with limited prior investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

von Willebrand FactorMutationPhenotypeGenetic Association StudiesHumansMaleFemaleAdultGermanyMiddle AgedYoung AdultAdolescentvon Willebrand DiseasesChildAgedChild, PreschoolCohort Studiesvon Willebrand Disease, Type 1Genetic Predisposition to DiseaseDNA Copy Number VariationsDNA Mutational AnalysisInfantvon Willebrand Disease, Type 3ABO Blood-Group System

Stichwörter der Autor:innen

blood groupscohort studiesmutationvon Willebrand diseasevon Willebrand factor

Substanzen

von Willebrand FactorABO Blood-Group System

Autor:innen und Institutionen

  • Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany.
  • Institute of Experimental Hematology and Transfusion Medicine, University Hospital Bonn, Bonn, Germany. Electronic address: hamideh.yadegari@ukbonn.de.
  • Center of Hemostasis, Medizinisches Versorgungszentrum Labor Leipzig, Leipzig, Germany.
  • Münster Hemostasis Center, Münster, Germany.
  • Laboratory and Ambulance for Coagulation Disorders, Duisburg, Germany.
  • Institute of Transfusion Medicine and Clinical Hemostaseology, Klinikum St. Georg GmbH, Leipzig, Germany.

Zitieren

APA

Krahforst, A., Yadegari, H., Pavlova, A., Pezeshkpoor, B., Müller, J., Pötzsch, B., Scholz, U., Richter, H., Trobisch, H., Liebscher, K., Olivieri, M., Trautmann-Grill, K., Knöfler, R., Halimeh, S., & Oldenburg, J. (2024). Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study. Journal of Thrombosis and Haemostasis, 22(11), 3010-3034. https://doi.org/10.1016/j.jtha.2024.06.026

Vancouver

Krahforst A, Yadegari H, Pavlova A, Pezeshkpoor B, Müller J, Pötzsch B, et al. Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study. Journal of Thrombosis and Haemostasis. 2024;22(11):3010-3034. doi:10.1016/j.jtha.2024.06.026

BibTeX
@article{Krahforst2024,
  author = {Krahforst, Alexander and Yadegari, Hamideh and Pavlova, Anna and Pezeshkpoor, Behnaz and Müller, Jens and Pötzsch, Bernd and Scholz, Ute and Richter, Heinrich and Trobisch, Heiner and Liebscher, Karin and Olivieri, Martin and Trautmann-Grill, Karolin and Knöfler, Ralf and Halimeh, Susan and Oldenburg, Johannes},
  title = {Unravelling the spectrum of von Willebrand factor variants in quantitative von Willebrand disease: results from a German cohort study},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2024},
  volume = {22},
  number = {11},
  pages = {3010--3034},
  doi = {10.1016/j.jtha.2024.06.026}
}
Kostenlos starten →